Poo power: Calgary study explores link between gut bacteria, fecal supplements and mental health

By Kevin Green

Published August 13, 2024

Could the answer to overcoming serious depression be found in a pill made from poop?

A research team from the University of Calgary’s Cumming School of Medicine (CSM) is launching a study to investigate the potential link between gut bacteria and depression, and whether downing a supplement of fecal matter could help with treatment.

“We are tapping into the gut-brain axis and power of the microbiome as a way to improve life and unlock new treatment options for individuals struggling with a variety of psychiatric conditions,” said Dr. Valerie Taylor, a member of the Hotchkiss Brain Institute at the CSM.

The study will explore the use of Fecal Microbiota Transplantation (FMT) as a treatment for Major Depressive Disorder.

FMT is a procedure in which healthy stool is transferred into the gut of a patient with a health condition.

While it is already used to treat severe stomach problems, researchers are curious if it can also alleviate symptoms of depression.

The Calgary study will last 13 weeks and involve 18 visits to Foothills Medical Center, where participants will receive ingest either FMT capsules or placebo pills, with a 50/50 chance of receiving either.

Researchers are looking for participants who are currently being treated for depression but continue to experience depressive episodes.

The research aims to determine if FMT is safe and effective in treating MDD.

If successful, researchers believe it could revolutionize the way mental health treatment is delivered.

In a different (but related) study, researchers are also examining the use of FMT to help individuals with Obsessive Compulsive Disorder.

Participants will be given FMT capsules and asked to provide stool, urine, saliva and blood samples, and will be followed on a weekly basis for a period of four months.

Share the Post:
Receive the latest news

Join Our Journey

Be the First to Know: Unlock exclusive updates on the progress and launch timeline of our groundbreaking biotherapeutics product development.

Name(Required)

Asem Bala

MSc

Asem Bala, MSc has over 20 years of experience in Healthcare & Clinical Research Management, now working at Taylored Biotherapeutics to create partnerships and ensure regulatory approvals.

Dr. Valerie Taylor

MD, PhD, FRCP

Dr. Valerie Taylor, MD, PhD, FRCP is a Professor of Psychiatry at the University of Calgary. She completed a Bachelor of Medical Science and graduated from medical school at Memorial University of Newfoundland. She subsequently finished her residency training in Psychiatry and got her PhD in Neuroscience from McMaster University in Hamilton, Ontario. Prior to coming to Calgary, she was the chief of Psychiatry at the Women’s College Hospital and the chief of Adult Health Services at the Center for Addiction and Mental Health in Toronto.

Her academic focus has been on the area of medical psychiatry – specifically, for the last 5 years, on the gut brain axis and the the gut microbiome. She is the only funded researcher in North America examining the therapeutic effects of fecal transplant as a treatment for mental health and she currently has 4 novel clinical trials looking at modifying the gut microbiome to treat mood disorders as well as the largest biological neuroscience microbiome repository in North America. She has over 180 peer reviewed publications and funding from a variety of national and international funding agencies. In 2020 she started Taylored Biotherapeutics, a micro therapeutics drug company. Today her primary role is in leading product development, getting regulatory approval, and finding partnerships.